Burden of Comorbid Conditions Among Individuals Screened for Lung Cancer.

ABSTRACT:

Importance

Screening for lung cancer with low-dose computed tomography (LDCT) has been shown to reduce lung cancer mortality in trials that included relatively younger, healthier, and predominantly White populations. The comorbidity profiles among patients undergoing lung cancer screening in practice settings are poorly understood.

Objective

To evaluate the comorbidity profiles of patients in the Personalized Lung Cancer Screening (PLuS) cohort as a clinical setting vs the National Lung Screening Trial (NLST) participants in a clinical trial setting.

Design, setting, and participants

This multicenter cohort study was conducted across 3 health care systems in California, Florida, and South Carolina and included patients who underwent LDCT lung cancer screening between

SUBMITTER: Braithwaite D 

PROVIDER: S-EPMC11846005 | biostudies-literature | 2025 Feb

REPOSITORIES: biostudies-literature